TREATMENT OF PATIENTS WITH MODERATE AND SEVERE PSORIASIS - COST-OF-ILLNESS IN THE CZECH REPUBLIC

被引：2
|
作者：
Petrikova, A. [1 ]
Klimes, J. [2 ]
Dolezal, T. [3 ]
Marinov, L.
Petrova, G. [4 ]
机构：
[1] VFU Brno, Brno, Czech Republic
[2] Charles Univ Prague, Fac Pharm, CS-50165 Hradec Kralove, Czech Republic
[3] Inst Hlth Econ & Technol Assessment, Prague, Czech Republic
[4] Med Univ, Fac Pharm, Sofia, Bulgaria
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 07期
关键词：
D O I：
10.1016/j.jval.2011.08.406
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A305 / A306
页数：2
相关论文
共 50 条
  • [41] CHRONIC HEART FAILURE (CHF) IN THE CZECH REPUBLIC: COST-OF-ILLNESS ANALYSIS & DISEASE BURDEN BASED ON AHEAD REGISTRY DATA MINING
    Spinar, J.
    Parenica, J.
    Klimes, J.
    Vesela, V.
    Blahovcova, M.
    Dostal, F.
    Vonka, R.
    VALUE IN HEALTH, 2017, 20 (09) : A610 - A610
  • [42] Tailored biological treatment for patients with moderate-to-severe psoriasis
    Maurelli, Martina
    Gisondi, Paolo
    Girolomoni, Giampiero
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2023, 19 (01) : 37 - 43
  • [43] Response to treatment with secukinumab in obese patients with moderate to severe psoriasis
    Krueger, James G.
    Pariser, David
    Muscianisi, Elisa
    Kianifard, Farid
    Steadman, Jennifer
    Sarkar, Rajendra Prasad
    Ehst, Benjamin D.
    Alexis, Andrew F.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB38 - AB38
  • [44] Ixekizumab for the treatment of pediatric patients with moderate to severe plaque psoriasis
    Cather, Jennifer Clay
    Young, Chaney T.
    Young, Melody S.
    Cather, J. Christian
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (08) : 983 - 990
  • [45] Pooled efficacy of infliximab for the treatment of patients with moderate to severe psoriasis
    Menter, A
    Papp, K
    Guzzo, C
    Li, S
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB222 - AB222
  • [46] Cost-Of-Illness Survey Of Patients With Food Hypersensitivity In Germany
    Koenig, V.
    Roesch, N.
    Moesges, R.
    Schmalz, P.
    Kohler, S.
    Arens-Volland, A.
    Herbst, R.
    Schnadt, S.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB115 - AB115
  • [47] Treatment Approaches to Moderate to Severe Psoriasis
    Gisondi, Paolo
    Del Giglio, Micol
    Girolomoni, Giampiero
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (11):
  • [48] Ustekinumab for the treatment of moderate to severe psoriasis
    Gospodarevskaya, E.
    Picot, J.
    Cooper, K.
    Loveman, E.
    Takeda, A.
    HEALTH TECHNOLOGY ASSESSMENT, 2009, 13 : 61 - 66
  • [49] Risankizumab for the treatment of moderate to severe psoriasis
    Chiricozzi, Andrea
    Antonioli, Luca
    Panduri, Salvatore
    Fornai, Matteo
    Romanelli, Marco
    Blandizzi, Corrado
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (01) : 1 - 8
  • [50] Gastrointestinal Comorbidities in Patients with Psoriasis in the Czech Republic
    Juzlova, K.
    Votrubova, J.
    Dzambova, M.
    Smerhovsky, Z.
    Gopfertova, D.
    Hercogova, J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S17 - S17
12345